Home > Insider Trading > Filing (0000899243-19-023102)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1133416	Galectin Therapeutics Inc	GALT	Pharmaceutical Preparations (2834)	043562325

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1522478	D Kevin Freeman	C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd., Suite 240 Norcross GA 30071		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-06	1,290	$3.71	11,000	No	4	P	Indirect	By a limited liability company wholly-owned by Freeman Global Holdings, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By a limited liability company wholly-owned by Freeman Global Holdings, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	23,469	Direct
Common Stock	16,000	Indirect	IRA

Footnotes

The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were purchased in multiple transactions at prices ranging from $3.705 to $3.713 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by the Reporting Person at each separate price on each date of purchase.
Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.